Joseph A. Bore

Macenta, N, Guinea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Cross-reactive Bundibugyo antibody responses in Guinean survivors of Ebola virus and recipients of rVSVΔG-ZEBOV-GP (Ervebo) in an outbreak setting.

Cross-reactive Bundibugyo antibody responses in Guinean survivors of Ebola virus and recipients of rVSVΔG-ZEBOV-GP (Ervebo) in an outbreak setting.

Journal: The Lancet. Infectious diseases
Published: August 14, 2026

Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping review.

Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping review.

Journal: The Lancet. Infectious diseases
Published: April 27, 2026

Performance of an envelope glycoprotein-based multiplex immunoassay for Ebola virus antibody detection in a cohort of Ebola virus disease survivors.

Performance of an envelope glycoprotein-based multiplex immunoassay for Ebola virus antibody detection in a cohort of Ebola virus disease survivors.

Journal: Journal of virological methods
Published: August 26, 2024

Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea.

Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea.

Journal: Emerging infectious diseases
Published: January 24, 2023

Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors.

Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors.

Journal: Journal of virology
Published: September 08, 2022

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks.

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks.

Journal: Nature
Published: April 06, 2021

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins.

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins.

Journal: Viruses
Published: June 30, 2020

Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemic.

Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemic.

Journal: Nature communications
Published: May 29, 2020

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies.

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies.

Journal: Scientific reports
Published: January 02, 2020

Expanding the Arterivirus Host Spectrum: Olivier's Shrew Virus 1, A Novel Arterivirus Discovered in African Giant Shrews.

Expanding the Arterivirus Host Spectrum: Olivier's Shrew Virus 1, A Novel Arterivirus Discovered in African Giant Shrews.

Journal: Scientific reports
Published: March 15, 2018

Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut.

Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut.

Journal: mSphere
Published: July 20, 2017

Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.

Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.

Journal: PLoS neglected tropical diseases
Published: February 06, 2017
Showing 1-12 of 22

Last Updated: 09/26/2026